α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways

被引：0
|
作者：
R Tiwary
W Yu
B G Sanders
K Kline
机构：
[1] School of Biological Sciences/C0900,Department of Nutritional Sciences/A2703
[2] University of Texas,undefined
[3] 1 University Station,undefined
[4] University of Texas,undefined
[5] 1 University Station,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
-TEA; Akt; breast cancer; ERK; IRS-1; mTOR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：101 / 109
页数：8
相关论文
共 50 条
  • [41] Synergistic targeting of the PI3K/mTOR and MAPK/ERK pathways in Merkel cell carcinoma
    Temblador, Arturo
    Topalis, Dimitrios
    Andrei, Graciela
    Snoeck, Robert
    TUMOUR VIRUS RESEARCH, 2022, 14
  • [42] Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways
    Rosenberg, Laura
    Yoon, Charles H.
    Sharma, Gaurav
    Bertagnolli, Monica M.
    Cho, Nancy L.
    CARCINOGENESIS, 2018, 39 (05) : 681 - 688
  • [43] Targeting PI3K/mTOR signaling in cutaneous angiosarcoma
    Wada, M.
    Horinaka, M.
    Sakai, T.
    Masuzawa, M.
    Katoh, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S56 - S56
  • [44] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [45] Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
    Zhou, S.
    Liu, L.
    Li, H.
    Eilers, G.
    Kuang, Y.
    Shi, S.
    Yan, Z.
    Li, X.
    Corson, J. M.
    Meng, F.
    Zhou, H.
    Sheng, Q.
    Fletcher, J. A.
    Ou, W-B
    BRITISH JOURNAL OF CANCER, 2014, 110 (10) : 2479 - 2488
  • [46] Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
    S Zhou
    L Liu
    H Li
    G Eilers
    Y Kuang
    S Shi
    Z Yan
    X Li
    J M Corson
    F Meng
    H Zhou
    Q Sheng
    J A Fletcher
    W-B Ou
    British Journal of Cancer, 2014, 110 : 2479 - 2488
  • [47] DUAL TARGETING OF PI3K AND mTOR SIGNALING IN MEDULLOBLASTOMA
    Clymer, Jessica
    Eckerdt, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2016, 18 : 112 - 112
  • [48] Targeting the PI3K/mTOR pathway hematologic malignancies
    Tasian, Sarah K.
    Teachey, David T.
    Rheingold, Susan R.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [49] Roles of Raf/MEK/ERK and PI3K/Akt/mTOR pathways in prevention of apoptosis and induction of drug resistance in myeloid hematopoietic cells
    Abrams, Steve L.
    Evangelisti, Camilla
    Chiarini, Francesca
    Misaghian, Negin
    Basecke, Jorg
    Millela, Michelle
    Tafuri, Agostino
    Libra, Massimo
    Stivala, Franca
    Konopleva, Marina
    Andreeff, Michael
    Steelman, Linda S.
    Troppmair, Jacob
    Martelli, Alberto M.
    McCubrey, James. A.
    BLOOD, 2007, 110 (11) : 197A - 198A
  • [50] Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
    Steelman, L. S.
    Abrams, S. L.
    Whelan, J.
    Bertrand, F. E.
    Ludwig, D. E.
    Baesecke, J.
    Libra, M.
    Stivala, F.
    Milella, M.
    Tafuri, A.
    Lunghi, P.
    Bonati, A.
    Martelli, A. M.
    McCubrey, J. A.
    LEUKEMIA, 2008, 22 (04) : 686 - 707
12345